Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Site Enhances New Modality CRDMO Platform Capacity for Customers
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
Subscribe To Our Newsletter & Stay Updated